Vexol is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc. The primary component is Rimexolone.
Product ID | 0065-0627_047301fe-73f6-356c-ec16-a1123037f239 |
NDC | 0065-0627 |
Product Type | Human Prescription Drug |
Proprietary Name | Vexol |
Generic Name | Rimexolone |
Dosage Form | Suspension/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 1995-09-15 |
Marketing Category | NDA / NDA |
Application Number | NDA020474 |
Labeler Name | Alcon Laboratories, Inc |
Substance Name | RIMEXOLONE |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1995-09-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020474 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1995-09-15 |
Marketing End Date | 2017-02-20 |
Marketing Category | NDA |
Application Number | NDA020474 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1995-09-15 |
Marketing End Date | 2011-07-28 |
Marketing Category | NDA |
Application Number | NDA020474 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1995-09-15 |
Marketing End Date | 2011-07-28 |
Marketing Category | NDA |
Application Number | NDA020474 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1995-09-15 |
Marketing End Date | 2016-03-10 |
Ingredient | Strength |
---|---|
RIMEXOLONE | 10 mg/mL |
SPL SET ID: | b1699f4e-40d5-49d0-ab80-1c8cc68e80a4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VEXOL 74479305 1960827 Live/Registered |
Alcon Laboratories, Inc. 1994-01-13 |